Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-asparaginase in Adult ALL
NCT00476190Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Apr 2007
- Primary completion
- Sep 2013
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Dana-Farber Cancer Institute. Started Apr 2007; status: completed.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00476190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476190.